Cardiovascular Revascularization Medicine
Scope & Guideline
Transforming Cardiovascular Interventions
Introduction
Aims and Scopes
- Percutaneous Coronary Intervention (PCI) Techniques:
The journal emphasizes innovative techniques and methodologies in PCI, exploring advancements in technologies such as drug-eluting stents, bioresorbable scaffolds, and various atherectomy methods. - Transcatheter Aortic Valve Replacement (TAVR):
A significant focus is on TAVR, including studies on procedural outcomes, device innovations, and patient selection criteria, particularly in high-risk populations. - Management of Cardiogenic Shock:
Research on the management strategies for cardiogenic shock, including the use of mechanical circulatory support devices like Impella and intra-aortic balloon pumps, is a prominent area. - Coronary Artery Disease and Its Complications:
The journal covers various aspects of coronary artery disease, including acute coronary syndromes, chronic total occlusions, and associated complications, fostering a deeper understanding of patient management. - Health Disparities in Cardiovascular Care:
Emerging themes in the journal include addressing health disparities in cardiovascular care, particularly regarding race, gender, and socioeconomic status, ensuring equitable treatment access and outcomes. - Innovative Imaging and Diagnostic Techniques:
The use of advanced imaging modalities, such as optical coherence tomography and intravascular ultrasound, to guide interventions and improve diagnostic accuracy is a key focus area.
Trending and Emerging
- Artificial Intelligence and Machine Learning:
The integration of AI and machine learning in predicting outcomes and optimizing treatment strategies is gaining traction, showcasing the potential for technology to enhance clinical decision-making. - Personalized Medicine:
There is an increasing emphasis on personalized medicine approaches, particularly regarding tailored therapies based on genetic, ethnic, and individual patient profiles, enhancing treatment efficacy. - Novel Devices and Techniques:
Research on innovative devices, such as next-generation transcatheter heart valves and advanced closure devices, is on the rise, reflecting an ongoing commitment to improving procedural success rates. - Focus on Patient-Centered Outcomes:
Emerging attention on patient-reported outcomes and quality of life measures post-intervention is becoming more prevalent, indicating a shift towards holistic patient care. - Management of Comorbidities:
The intersection of cardiovascular disease with other health conditions, such as diabetes, chronic kidney disease, and cancer, is increasingly explored, addressing the complexity of patient management. - Post-Procedure Complications and Outcomes:
Research into the long-term outcomes and complications following various interventions, particularly in high-risk populations, is trending, emphasizing the importance of follow-up care.
Declining or Waning
- Traditional Surgical Approaches:
There is a noticeable decline in focus on traditional surgical revascularization methods, such as coronary artery bypass grafting (CABG), as newer, less invasive techniques gain preference. - Outdated Technologies:
Research on older technologies, such as bare-metal stents and first-generation drug-eluting stents, is less frequent, indicating a shift towards more advanced and effective treatment options. - General Patient Population Studies:
Studies focusing on broad, general patient populations without specific sub-group analysis are becoming less common, as the journal increasingly prioritizes research that addresses specific, high-risk populations or novel interventions. - Basic Science Research:
There is a waning interest in basic science research related to cardiovascular interventions. The journal now favors clinical studies that provide direct implications for practice and patient outcomes.
Similar Journals
EuroIntervention
Transforming Research into Clinical Impact in CardiologyEuroIntervention is a prestigious academic journal dedicated to the field of cardiology and cardiovascular medicine, published by EUROPA EDITION. Established as an essential resource for researchers and healthcare professionals, the journal holds an impressive Q1 ranking in both Cardiology and Cardiovascular Medicine as of 2023, demonstrating its influence and commitment to advancing knowledge in these fields. With an ISSN of 1774-024X and an E-ISSN of 1969-6213, EuroIntervention aims to publish high-quality research and clinical studies that address contemporary challenges in cardiovascular therapies. The journal is recognized for its rigorous peer-review process, ensuring that each article contributes valuable insights to the community. Researchers will find EuroIntervention a vital platform to disseminate their findings and engage with innovative cardiology techniques. Operating from France, the journal aspires to bridge the gap between research and clinical practice, making it an essential read for cardiologists, medical professionals, and students alike, keen to stay abreast of the latest advancements in cardiovascular care.
JACC-Cardiovascular Interventions
Leading the Charge in Cardiovascular Intervention KnowledgeJACC: Cardiovascular Interventions is a premier journal dedicated to the field of cardiology and cardiovascular medicine, published by Elsevier Science Inc. This esteemed journal, with an ISSN of 1936-8798 and an E-ISSN of 1876-7605, has established itself as a leading platform for disseminating cutting-edge research and advancements from 2008 to the present, and is projected to continue until 2024. Recognized for its rigorous peer-review process and high-quality content, JACC: Cardiovascular Interventions holds a prestigious Q1 ranking in both Cardiology and Cardiovascular Medicine as well as a Q1 ranking in the broader category of Medicine (Miscellaneous) as of 2023. With a Scopus rank of #25 out of 387 in its field, placing it in the 93rd percentile, the journal is a vital resource for researchers, healthcare professionals, and students alike. Although it does not currently offer open access, its essential contributions to the medical community underscore its importance in advancing cardiovascular intervention knowledge and practice.
HEART AND VESSELS
Elevating Standards in Cardiovascular Research and PracticeHEART AND VESSELS is a prominent peer-reviewed journal published by SPRINGER, dedicated to advancing the fields of cardiology and cardiovascular medicine. With its ISSN 0910-8327 and E-ISSN 1615-2573, this esteemed journal encompasses a broad range of topics pertinent to heart health, vascular function, and associated therapies, making it an essential resource for researchers, clinicians, and healthcare professionals alike. Based in Japan and operating since 1985, HEART AND VESSELS has consistently maintained a Q2 ranking in the 2023 category quartiles, highlighting its relevance and impact in the cardio domain. Although it does not offer open access, the journal ensures high-quality publications that contribute significantly to the academic and clinical understanding of cardiovascular health. With over three decades of continuous scholarly contribution, HEART AND VESSELS serves as a vital platform for disseminating cutting-edge research and fostering innovative practices in the management of cardiovascular diseases.
JOURNAL OF INVASIVE CARDIOLOGY
Pioneering Research in Cardiovascular MedicineJOURNAL OF INVASIVE CARDIOLOGY, a reputable publication by H M P COMMUNICATIONS, is dedicated to advancing the field of cardiology and cardiovascular medicine through rigorous research and scholarly discussion. With an ISSN of 1042-3931 and an E-ISSN of 1557-2501, this journal serves as a crucial resource for healthcare professionals, researchers, and students who seek to stay informed about the latest findings and innovations in invasive cardiology. Having achieved a 2023 Scopus rank of #185 out of 636 in General Medicine, placing it in the 70th percentile, the journal is recognized for its significant contributions to medical science, evidenced by its Q2 ranking in Radiology, Nuclear Medicine and Imaging, and Q3 status in both Cardiology and Cardiovascular Medicine. The journal has been in circulation since 1990 and continues to foster a platform for critical research in the United States, ensuring accessibility to vital information necessary for enhancing patient care and clinical practices within the domain of invasive procedures.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
Pioneering research for a healthier heart and lungs.JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, published by Mosby-Elsevier, stands as a leading peer-reviewed journal dedicated to advancing the fields of thoracic and cardiovascular surgery. With an impressive impact factor reflecting its rigorous standards and significance, this journal occupies prestigious Q1 quartiles in 2023 across Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, as well as Surgery. Additionally, it boasts remarkable rankings in the Scopus database, being placed at #8 in Surgery and #29 in Cardiology and Cardiovascular Medicine, underscoring its pivotal role in disseminating high-quality research and clinical insights. Its scope encompasses vital areas such as surgical techniques, innovative therapies, and patient outcomes, making it an essential resource for researchers, clinicians, and students passionate about advancing cardiac and pulmonary health. Though not an open-access journal, it ensures that subscribers and institutional partners can access valuable research contributions published within its pages from 1959 to 2024. The JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY continues to shape the future of surgical practices and enhance patient care on a global scale.
ACTA CARDIOLOGICA
Exploring the forefront of cardiac research.ACTA CARDIOLOGICA is a distinguished journal published by TAYLOR & FRANCIS LTD, focusing on the dynamic fields of Cardiology and Cardiovascular Medicine. Established in 1946, the journal has maintained a significant presence in the academic community, providing a platform for cutting-edge research and clinical studies that aim to address challenges in cardiovascular health. With its Q3 rating in both Cardiology and General Medicine categories, it showcases a robust compilation of articles that reflect the evolving landscape of cardiac care. Although ACTA CARDIOLOGICA is not an Open Access journal, it continues to serve a vital role for researchers, professionals, and students dedicated to advancing knowledge in cardiovascular health. This journal, with an ISSN of 0001-5385 and E-ISSN of 1784-973X, is a critical resource for those looking to stay updated on the latest developments and practices in the specialization, contributing significantly to the field until 2024 and beyond.
AMERICAN JOURNAL OF CARDIOLOGY
Driving Innovation in Heart Health and Clinical OutcomesThe American Journal of Cardiology is a leading peer-reviewed journal in the field of Cardiology and Cardiovascular Medicine, published by Excerpta Medica Inc-Elsevier Science Inc. Since its inception in 1958, the journal has consistently contributed to the advancement of cardiovascular research, providing a platform for groundbreaking studies and clinical findings that shape modern medical practices. With an impressive impact factor placing it in the Q1 category in its field for 2023, it ranks among the top journals in medicine, with a rank of #155 out of 387 in the Scopus database, reflecting its significance and rigorous editorial standards. The journal is committed to disseminating high-quality research that fosters innovation and enhances clinical outcomes in cardiology. Although it does not provide Open Access options, the American Journal of Cardiology remains an essential resource for researchers, healthcare professionals, and students looking to deepen their understanding of cardiovascular health.
Indian Journal of Thoracic and Cardiovascular Surgery
Exploring Innovations in Cardiac and Pulmonary SurgeryIndian Journal of Thoracic and Cardiovascular Surgery, published by SPRINGER INDIA, serves as a vital platform for the dissemination of innovative research and clinical advancements in the fields of cardiology, cardiovascular medicine, pulmonary, and respiratory medicine. With a rich history dating back to 1982 and spanning multiple years through to 2024, this journal aims to provide a comprehensive view of both theoretical and practical aspects of thoracic and cardiovascular surgery. Although it currently holds a Q3 quartile ranking across various relevant categories, researchers and practitioners can benefit from its insightful articles that contribute to ongoing discussions and advancements in these critical medical areas. The journal does not offer open access presently, yet it is accessible through major academic databases, providing valuable resources for professionals and students keen on enhancing their understanding and expertise. In a rapidly evolving field marked by technological advancements and novel research, the Indian Journal of Thoracic and Cardiovascular Surgery remains integral to fostering collaboration and education among its audience.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
Leading the Charge in Cardiovascular Innovation and ExcellenceCatheterization and Cardiovascular Interventions is a leading peer-reviewed journal published by Wiley, dedicated to advancing the fields of cardiology, cardiovascular medicine, and radiology. With an impressive impact factor and categorized in the Q1 quartile across multiple disciplines—including Cardiology, Medicine, and Radiology—this journal serves as an essential resource for researchers, clinicians, and students interested in the latest developments in minimally invasive techniques and innovative cardiovascular therapies. Since its inception in 1999 and continuing through 2024, Catheterization and Cardiovascular Interventions has provided a platform for high-quality original research, reviews, and case studies, highlighting approaches that improve patient outcomes and treatment methodologies. Operating from the United States, the journal offers various access options, making key findings in cardiovascular interventions readily available to its audience. Stay at the forefront of cardiovascular innovation by engaging with this pivotal publication.
Korean Circulation Journal
Elevating Cardiovascular Science Through Innovative Research.Korean Circulation Journal, published by the Korean Society of Cardiology, has established itself as a prominent platform for disseminating research in the fields of Cardiology and Cardiovascular Medicine. With an ISSN of 1738-5520 and an E-ISSN of 1738-5555, this journal has been at the forefront of cardiovascular science since its inception in 2006 and is projected to continue until 2024. The journal's commitment to quality is reflected in its 2023 category quartiles, ranking in the second quartile (Q2) for both Cardiology and Internal Medicine, as well as its commendable Scopus rankings within the respective fields. Located in South Korea, the journal aims to bridge the gap between cutting-edge research and practical applications, serving as an invaluable resource for researchers, healthcare professionals, and students keen on advancing their understanding of cardiovascular health. Although currently not an open-access journal, it provides a wealth of knowledge that encourages evidence-based practice in clinical settings.